Many do not realize the importance of Doc being on the Board of Directors at the University of Maryland Biopark. That is where he was working with Paragon Bioseciences. They were bought out by Catalent. The DEA research and contract manufacturing aspects of the conglomerate are made possible thanks to Catalent being FDA approved. This is going to be HUGE for us. Doc is a visionary extraordinaire!
#MJCONGLOMERATE